• 410 Citations
20082020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 410 Citations
  • 18 Article
  • 6 Review article
  • 1 Chapter
  • 1 Short survey
2020

Hematopoietic growth factors, version 1.2020: Featured updates to the NCCN guidelines

Becker, P. S., Griffiths, E. A., Alwan, L. M., Bachiashvili, K., Brown, A., Cool, R., Curtin, P., Dinner, S., Gojo, I., Hicks, A., Kallam, A., Kidwai, W. Z., Kloth, D. D., Kraut, E. H., Landsburg, D., Lyman, G. H., Miller, R., Mukherjee, S., Patel, S., Perez, L. E. & 13 others, Poust, A., Rampal, R., Rosovsky, R., Roy, V., Rugo, H. S., Shayani, S., Vasu, S., Wadleigh, M., Westbrook, K., Westervelt, P., Burns, J., Keller, J. & Pluchino, L. A., Jan 1 2020, In : JNCCN Journal of the National Comprehensive Cancer Network. 18, 1, p. 12-22 11 p.

Research output: Contribution to journalArticle

Open Access
7 Scopus citations

Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab

Badar, T., Szabo, A., Advani, A., Wadleigh, M., Arslan, S., Khan, M. A., Aldoss, I., Siebenaller, C., Schultz, E., Hefazi, M., Shallis, R. M., Yurkiewicz, I., Podoltsev, N., Patel, A. A., Curran, E., Balasubramanian, S., Yang, J., Mattison, R. J., Burkart, M., Dinner, S. & 3 others, Liedtke, M., Litzow, M. R. & Atallah, E., May 26 2020, In : Blood Advances. 4, 10, p. 2308-2316 9 p.

Research output: Contribution to journalArticle

Open Access

Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin

Badar, T., Szabo, A., Wadleigh, M., Liedtke, M., Arslan, S., Siebenaller, C., Aldoss, I., Schultz, E., Hefazi, M., Litzow, M. R., Kuo, E., Wang, A., Curran, E., Shallis, R. M., Podoltsev, N., Balasubramanian, S., Yang, J., Mattison, R., Burkart, M., Dinner, S. & 2 others, Advani, A. & Atallah, E., Aug 2020, In : Clinical Lymphoma, Myeloma and Leukemia. 20, 8, p. 556-560.e2

Research output: Contribution to journalArticle

2019

Future health of AYA survivors

Burkart, M., Sanford, S., Dinner, S., Sharp, L. & Kinahan, K., Feb 1 2019, In : Pediatric Blood and Cancer. 66, 2, e27516.

Research output: Contribution to journalReview article

8 Scopus citations

Moxetumomab pasudotox for hairy cell leukemia: Preclinical development to FDA approval

Lin, A. Y. & Dinner, S. N., Oct 8 2019, In : Blood Advances. 3, 19, p. 2905-2910 6 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations
2018

Acute Lymphoblastic Leukemia in Adults

Dinner, S., Gurbuxani, S., Jain, N. & Stock, W., Jan 1 2018, Hematology: Basic Principles and Practice. Elsevier Inc, p. 1029-1054.e2

Research output: Chapter in Book/Report/Conference proceedingChapter

Adolescent and young adult oncology, version 2.2018: Clinical practice guidelines in oncology

Coccia, P. F., Pappo, A. S., Beaupin, L., Borges, V. F., Borinstein, S. C., Chugh, R., Dinner, S., Folbrecht, J., Frazier, A. L., Goldsby, R., Gubin, A., Hayashi, R., Huang, M. S., Link, M. P., Livingston, J. A., Matloub, Y., Millard, F., Oeffinger, K. C., Puccetti, D., Reed, D. & 10 others, Robinson, S., Rosenberg, A. R., Sanft, T., Spraker-Perlman, H. L., Von Mehren, M., Wechsler, D. S., Whelan, K. F., Yeager, N., Gurski, L. A. & Shead, D. A., Jan 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 1, p. 66-97 32 p.

Research output: Contribution to journalReview article

54 Scopus citations

Antibody-based therapies in patients with acute lymphoblastic leukemia

Dinner, S. & Liedtke, M., Nov 30 2018, In : Hematology (United States). 2018, 1, p. 9-15 7 p.

Research output: Contribution to journalArticle

Open Access
9 Scopus citations

A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma

Dinner, S., Dunn, T. J., Price, E., Coutré, S. E., Gotlib, J., Berube, C., Kaufman, G. P., Medeiros, B. C. & Liedtke, M., Sep 1 2018, In : International journal of hematology. 108, 3, p. 267-273 7 p.

Research output: Contribution to journalArticle

1 Scopus citations

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Kreitman, R. J., Dearden, C., Zinzani, P. L., Delgado, J., Karlin, L., Robak, T., Gladstone, D. E., le Coutre, P., Dietrich, S., Gotic, M., Larratt, L., Offner, F., Schiller, G., Swords, R., Bacon, L., Bocchia, M., Bouabdallah, K., Breems, D. A., Cortelezzi, A., Dinner, S. & 23 others, Doubek, M., Gjertsen, B. T., Gobbi, M., Hellmann, A., Lepretre, S., Maloisel, F., Ravandi, F., Rousselot, P., Rummel, M., Siddiqi, T., Tadmor, T., Troussard, X., Yi, C. A., Saglio, G., Roboz, G. J., Balic, K., Standifer, N., He, P., Marshall, S., Wilson, W., Pastan, I., Yao, N. S. & Giles, F., Aug 1 2018, In : Leukemia. 32, 8, p. 1768-1777 10 p.

Research output: Contribution to journalArticle

73 Scopus citations
2017
2 Scopus citations

Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopenia

Waisbren, J., Dinner, S., Altman, J., Frankfurt, O., Helenowski, I., Gao, J., McMahon, B. J. & Stein, B. L., Jan 1 2017, In : International journal of hematology. 105, 1, p. 44-51 8 p.

Research output: Contribution to journalArticle

4 Scopus citations

Epistaxis, ecchymoses, and an abnormal white blood cell count

Sellers, M. H. & Dinner, S. N., Jul 25 2017, In : JAMA - Journal of the American Medical Association. 318, 4, p. 383-384 2 p.

Research output: Contribution to journalArticle

1 Scopus citations

Myeloid growth factors, version 2.2017

Crawford, J., Becker, P. S., Armitage, J. O., Blayney, D. W., Chavez, J., Curtin, P., Dinner, S., Fynan, T., Gojo, I., Griffiths, E. A., Hough, S., Kloth, D. D., Kuter, D. J., Lyman, G. H., Mably, M., Mukherjee, S., Patel, S., Perez, L. E., Poust, A., Rampal, R. & 12 others, Roy, V., Rugo, H. S., Saad, A. A., Schwartzberg, L. S., Shayani, S., Talbott, M., Vadhan-Raj, S., Vasu, S., Wadleigh, M., Westervelt, P., Burns, J. L. & Pluchino, L., Dec 1 2017, In : JNCCN Journal of the National Comprehensive Cancer Network. 15, 12, p. 1520-1541 22 p.

Research output: Contribution to journalReview article

45 Scopus citations
2016

A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma

Dunn, T. J., Dinner, S., Price, E., Coutré, S. E., Gotlib, J., Hao, Y., Berube, C., Medeiros, B. C. & Liedtke, M., Apr 1 2016, In : British Journal of Haematology. 173, 2, p. 253-259 7 p.

Research output: Contribution to journalArticle

Targeting the mTOR Pathway in Leukemia

Dinner, S. N. & Platanias, L. C., Aug 1 2016, In : Journal of Cellular Biochemistry. p. 1745-1752 8 p.

Research output: Contribution to journalReview article

32 Scopus citations
2015

Fatigue and an elevated white blood cell count

Sellers, M. H. & Dinner, S. N., Aug 11 2015, In : JAMA - Journal of the American Medical Association. 314, 6, p. 617-618 2 p.

Research output: Contribution to journalShort survey

2014

AL amyloidosis or multiple myeloma? An important distinction - response to Falk

Dinner, S. & Liedtke, M., Mar 1 2014, In : British Journal of Haematology. 164, 5, p. 749-750 2 p.

Research output: Contribution to journalArticle

Current therapy and novel agents for relapsed or refractory acute lymphoblastic leukemia

Dinner, S., Lee, D. & Liedtke, M., Jan 1 2014, In : Leukemia and Lymphoma. 55, 8, p. 1715-1724 10 p.

Research output: Contribution to journalReview article

16 Scopus citations

New strategies for relapsed acute myeloid leukemia: Fertile ground for translational research

Dinner, S. N., Giles, F. J. & Altman, J. K., Mar 1 2014, In : Current Opinion in Hematology. 21, 2, p. 79-86 8 p.

Research output: Contribution to journalReview article

13 Scopus citations

Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia

Liedtke, M., Dunn, T., Dinner, S., Coutré, S. E., Berube, C., Gotlib, J., Patel, S. & Medeiros, B., Dec 1 2014, In : Leukemia Research. 38, 12, p. 1441-1445 5 p.

Research output: Contribution to journalArticle

5 Scopus citations
2013

Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement

Dinner, S., Witteles, W., Afghahi, A., Witteles, R., Arai, S., Lafayette, R., Schrier, S. L. & Liedtke, M., Oct 1 2013, In : Haematologica. 98, 10, p. 1593-1599 7 p.

Research output: Contribution to journalArticle

45 Scopus citations

Targeted therapy in relapsed classical Hodgkin lymphoma

Dinner, S. & Advani, R., Aug 1 2013, In : JNCCN Journal of the National Comprehensive Cancer Network. 11, 8, p. 968-976 9 p.

Research output: Contribution to journalArticle

6 Scopus citations

The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis

Dinner, S., Witteles, W., Witteles, R., Lam, A., Arai, S., Lafayette, R., George, T. I., Schrier, S. L. & Liedtke, M., May 2013, In : British Journal of Haematology. 161, 3, p. 367-372 6 p.

Research output: Contribution to journalArticle

25 Scopus citations
2008

Of more than one mind: Obstetrician-gynecologists' approaches to morally controversial decisions in sexual and reproductive healthcare

Curlin, F. A., Dinner, S. N. & Lindau, S. T., Mar 1 2008, In : Journal of Clinical Ethics. 19, 1, p. 11-21 11 p.

Research output: Contribution to journalArticle

5 Scopus citations

Pretreatment C-Reactive Protein Is a Predictor for Outcomes after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation

Artz, A. S., Wickrema, A., Dinner, S., Godley, L. A., Kocherginsky, M., Odenike, O., Rich, E. S., Stock, W., Ulaszek, J., Larson, R. A. & van Besien, K., Nov 2008, In : Biology of Blood and Marrow Transplantation. 14, 11, p. 1209-1216 8 p.

Research output: Contribution to journalArticle

57 Scopus citations